The family of a 20-year-old Indiana woman who died from side effects of the Ortho Evra patch has filed a lawsuit against its manufacturer. The family claims in its Ortho Evra lawsuit that Ortho-McNeil failed to adequately warn the public about the patch’s health risks.
Two former paper mill workers from Maine have filed lawsuits against the asbestos manufacturers and suppliers whose products, they say, caused them to contract mesothelioma.
An upcoming study in the New England Journal of Medicine has found that patients taking the antibiotic Tequin are at risk for potentially deadly side effects, regardless of prior health conditions. The study, which will be published in the NEJM later this month, was released early on the Internet due to its public health implications.
Concerns about the safety of the Ortho Evra patch are leading the Food and Drug Administration to conduct “an exhaustive review” into the safety of medical patches in general.
Medicated patches, used by millions of people for a variety of ailments, can be rendered unsafe when heated by exercise, or when their wearers soak in a hot tub or have a high fever. Most patients do not realize this and should be warned, experts say.
More than two dozen women from Missouri and Illinois have filed an Ortho Evra lawsuit against Ortho-McNeil, maker of the Ortho Evra patch. The women claim that Ortho-McNeil didn’t do enough testing on the safety of the Ortho Evra patch before it was released in 2002. As a result, they were unaware of the serious side effects that taking the Ortho Evra patch could cause.
Two new studies about the potentially deadly side effects of the antibiotic Tequin have led a scientist to say that the Food and Drug Administration should not only issue a black-box warning, but that the drug should be banned outright. Dr. Jerry Gurwitz of the Meyers Primary Care Institute in Worcester, Massachusetts made his remarks in an editorial that will be published with one of the studies in the New England Journal of Medicine later this month.
A new study has found that older patients taking the antibiotic Tequin tend to suffer life-threatening changes in blood sugar levels. The research, conducted at the Institute for Clinical Evaluative Sciences in Toronto, is due to appear in the March 30 issue of the New England Journal of Medicine.
In the spring of 2005, Guidant was coming under increasing criticism for failing to tell doctors about certain potentially defective heart devices. At the same time, the company maintained a sunny outlook for the public. It insisted that its products were safe and that criticism of them was unfair and even irresponsible.
Bausch & Lomb has announced that it will not suspend sales of ReNu with MoistureLoc in Malaysia despite a suspected link between the contact lens solution and outbreaks of a potentially blinding eye infection. The company says that because there have been no cases of Fusarium keratitis symptoms in Malaysia, there is no reason for it to suspend MoistureLoc sales there.